Evotec SE: High-Risk Turnaround Play with Strong Strategic Partnerships and Biologics-Driven Growth Potential
Overview
Evotec SE is a German life sciences leader offering integrated drug discovery and development services for global pharma and biotech partners. The company’s two main divisions—Discovery & Preclinical and the rapidly growing Just – Evotec Biologics—cover the entire R&D value chain. Recent financial adversity prompted a full-scale strategic overhaul (the 'Priority Reset'), aiming to align costs with revenue and sharpen focus on core scientific strengths. The turnaround’s success is pivotal for restoring profitability and unlocking shareholder value, making this a critical inflection point for Evotec.